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Contact-dependent growth inhibition (CDI) is one
mechanism of inter-bacterial competition. CDI+ cells
export large CdiA effector proteins, which carry a
variety of C-terminal toxin domains (CdiA-CT).
CdiA-CT toxins are specifically neutralized by
cognate CdiI immunity proteins to protect toxin-
producing cells from autoinhibition. Here, we use
structure determination to elucidate the activity of a
CDI toxin from Enterobacter cloacae (ECL). The
structure of CdiA-CTECL resembles the C-terminal
nuclease domain of colicin E3, which cleaves 16S
ribosomal RNA to disrupt protein synthesis. In
accord with this structural homology, we show that
CdiA-CTECL uses the same nuclease activity to inhibit
bacterial growth. Surprisingly, although colicin E3
and CdiAECL carry equivalent toxin domains, the
corresponding immunity proteins are unrelated in
sequence, structure, and toxin-binding site.
Together, these findings reveal unexpected diversity
among 16S rRNases and suggest that these nucle-
ases are robust and versatile payloads for a variety
of toxin-delivery platforms.
INTRODUCTION
Bacterial genomes and plasmids encode a variety of peptide and
protein toxins that mediate inter-bacterial competition. Colicins
were the first of such toxins to be identified and characterized
from strains of Escherichia coli. Subsequently, it was discovered
that other bacteria release similar toxins, which are now collec-
tively termed bacteriocins (Cascales et al., 2007). Bacteriocins
are diffusible proteins that parasitize cell-envelope proteins to
enter and kill bacteria. These toxins are composed of three
domains, each responsible for a distinct step in the cell-killing
pathway. The central domain binds specific receptors on the
surface of susceptible bacteria. TheN-terminal domainmediates
translocation across the cell envelope, and the C-terminal
domain carries the bacteriocidal activity. This modular structure
allows for delivery of diverse C-terminal toxins using conservedStructure 22translocation and receptor-binding domains. For example, coli-
cins E2 through E9 share virtually identical N-terminal domains
but carry different C-terminal toxins with DNase (Schaller and
Nomura, 1976), ribosomal RNase (Bowman et al., 1971; Senior
and Holland, 1971), or tRNA anticodon nuclease activities
(Ogawa et al., 1999). Bacteriocin genes are always closely linked
to immunity genes, which encode small proteins that specifically
bind and neutralize the toxin domains. Thus, cells that harbor
bacteriocinogenic plasmids are protected from toxin activity,
but they may still be susceptible to the bacteriocins produced
from other plasmids. Many different bacteriocin/immunity types
are typically present in a given environment (Gordon et al., 1998;
Riley and Gordon, 1992), and these plasmids are predicted to
have a significant impact on bacterial population structures
(Chao and Levin, 1981; Cza´ra´n et al., 2002).
Research over the past decade has uncovered additional
bacterial competition systems that require direct cell-to-cell
contact for toxin delivery (Aoki et al., 2005, 2010; Hood et al.,
2010; MacIntyre et al., 2010; Zheng et al., 2011). There are at
least two pathways—mediated by type V and type VI secretion
systems—for contact-dependent toxin delivery between
Gram-negative bacteria (Ruhe et al., 2013a; Silverman et al.,
2012). The type V mechanism was the first identified, and this
phenomenon was termed ‘‘CDI’’ for contact-dependent growth
inhibition (Aoki et al., 2005). CDI is mediated by the CdiB/CdiA
family of two-partner secretion proteins. CdiB is a predicted
b-barrel protein that resides in the outer membrane and is
required for export of CdiA effectors. CdiA proteins are very large
(250–600 kDa) and are thought to extend from the inhibitor cell to
interact with neighboring target bacteria. Although CdiA and
bacteriocins are unrelated, these effector proteins share a
number of general features. Like bacteriocins, CdiA proteins
bind to specific receptors on the surface of target bacteria,
and these interactions determine the target-cell range (Aoki
et al., 2008; Ruhe et al., 2013b). Additionally, CDI toxin activity
is carried at the extreme C terminus of CdiA, and some portion
of this CdiA-CT region is translocated into target bacteria (Aoki
et al., 2010; Morse et al., 2012; Webb et al., 2013). CDI loci
also encode CdiI immunity proteins, which bind and inactivate
CdiA-CTs to protect toxin-producing cells from autoinhibition.
Finally, CDI systems deploy a variety of toxin domains with
distinct biochemical activities. Remarkably, chimeric CDI
effectors can be produced by fusing different toxins onto CdiA
at the conserved VENN peptide motif that demarcates the, 707–718, May 6, 2014 ª2014 Elsevier Ltd All rights reserved 707
Structure
A CDI Toxin from Enterobacter cloacaeCdiA-CT region (Aoki et al., 2010). There is also evidence that
bacteria exchange cdiA-CT/cdiI genes through horizontal
transfer (Poole et al., 2011), suggesting that effector modularity
is exploited to switch toxin/immunity type. In fact, bacteria
collectively contain a large repository of toxin/immunity genes
that are shared by a variety of toxin-delivery systems (Holberger
et al., 2012; Poole et al., 2011; Zhang et al., 2011, 2012). For
example, at least two CdiA proteins carry toxins with homology
to bacteriocin nucleases. CdiADd3937 from Dickeya dadantii
3937 carries a CT domain with 35% identity to the pyocin S3
DNase domain (Aoki et al., 2010), and the C-terminal region of
CdiAK96243 from Burkholderia pseudomallei K96243 is 49%
identical to the anticodon tRNase domain of colicin E5.
Biochemical analyses have confirmed that each of these CDI
toxins has the same nuclease activity as the corresponding
bacteriocin (Aoki et al., 2010; Nikolakakis et al., 2012). Together,
these observations suggest that CDI loci integrate toxin/immu-
nity gene pairs from diverse sources and that this diversity con-
tributes to inter-strain competition.
In an effort to understand CDI toxin/immunity diversity and
uncover toxin activities, we have initiated structural studies of
CdiA-CT/CdiI pairs from various bacteria. Here, we describe
the structure and function of the CDI toxin/immunity protein
pair from Enterobacter cloacae ATCC 13047 (ECL). The
CdiA-CTECL toxin shares no significant sequence identity with
proteins of known function, but the three-dimensional structure
of CdiA-CTECL reveals similarity to the C-terminal nuclease
domain of colicin E3. In accordance with the structural homol-
ogy, CdiA-CTECL cleaves 16S rRNA at the same site as colicin
E3, and this nuclease activity is responsible for growth inhibition.
By contrast, CdiIECL does not resemble the colicin E3 immunity
protein (ImE3), and the two immunity proteins bind to different
sites on their respective cognate toxin domains. Inspection of
other CdiA proteins from Erwinia chrysanthemi EC16 (Uniprot
ID code P94772), Enterobacter hormaechei ATCC 49162
(Uniprot ID code F5S237), and Pseudomonas viridiflava
UASWS0038 (Uniprot ID code K6CF79) has revealed that their
toxin domains share a common nuclease motif with colicin E3
(Walker et al., 2004). Analysis of CdiA-CTEC16 from Erwinia chrys-
anthemi EC16 confirms that this toxin has 16S rRNase activity
and demonstrates that the associated CdiIEC16 immunity protein
is specific to CdiA-CTEC16 and does not provide protection
against the CdiA-CTECL nuclease. Together, these observations
indicate that 16S rRNase toxins are more diverse and wide-
spread than previously recognized.
RESULTS
Crystallization and Structure of the CdiA-CTECL/CdiIECL
Complex
In a previous study, we used structural analysis to determine
the activities of CDI toxins from E. coli EC869 and B. pseudo-
mallei 1026b (Morse et al., 2012). Because the CDI toxin/
immunity pair from E. cloacae ATCC 13047 shares no
sequence homology with proteins of known function, we fol-
lowed a similar structure-based approach to characterize this
system. The CdiA-CTECL region is demarcated by the AENN
peptide motif and corresponds to residues Ala3087 to
Asp3321 of full-length CdiAECL. We coexpressed CdiA-CTECL708 Structure 22, 707–718, May 6, 2014 ª2014 Elsevier Ltd All rightswith His6-tagged CdiI
ECL and purified the complex to near
homogeneity (Figure S1A available online). The N-terminal
region of CdiA-CTECL was partially degraded during crystalli-
zation (Figure S1A), presumably because this region is disor-
dered. Similar N-terminal degradation has been observed
with other CdiA-CTs (Morse et al., 2012). The CdiA-CTECL/
CdiIECL complex crystallized in space group P4122 with one
heterodimeric complex per asymmetric unit (Figure S1B). The
structure was solved by selenium multiple wavelength anoma-
lous dispersion (Se-MAD) phasing to 2.4 A˚ resolution. The final
refined model contains CdiA-CTECL residues 160–235
(numbered from Ala1 of the AENN motif) and CdiIECL residues
1–145. In addition, 62 well-resolved water molecules are
included in the final model, resulting in a Rwork/Rfree of 18.3/
23.7 (Table 1).
The resolved C-terminal domain of CdiA-CTECL consists of an
N-terminal a helix, followed by a twisted five-stranded antipar-
allel b sheet (Figure 1A). The domain contains two long loops,
L2 and L4, which connect b1 to b2 and b3 to b4, respectively
(Figure 1A). Weak electron density was observed for loop L4,
likely because of its flexibility, and thus Ser206–Asn211 were
modeled as alanine residues. The CdiIECL immunity protein
comprises three- and four-stranded antiparallel b sheets, form-
ing a b sandwich that is decorated with three a helices (Fig-
ure 1A). The toxin and immunity protein interface is elaborate
and mediated by a series of hydrogen-bond (H-bond), electro-
static, and hydrophobic interactions (Figures 1B; Table S1).
CdiA-CTECL residues within loops L2–L6 form H-bonds and
ion-pair interactions with CdiIECL residues in loops L10, L20, and
L30 and the edge of the b sandwich (b30, b50, and b60) (Figure 1B).
A water-mediated network of H-bonds also contributes to the
interface, resulting in more than 20 ion-pair/H-bond interactions
between toxin and immunity proteins (Figure 1B; Table S1). In
addition, there is a hydrophobic interface of approximately
300 A˚2 consisting of Ile178, Val192, Tyr199, and Phe216 from
CdiA-CTECL, and Phe76, Phe78, Val95, and Phe97 from CdiIECL
(Figure 1C). Overall, the CdiA-CTECL/CdiIECL complex has an
interface of 1,399 A˚2, burying 27.6% and 17.1% of the solvent-
accessible surface areas of the toxin and immunity proteins,
respectively.
CdiA-CTECL Is Structurally Homologous to the Nuclease
Domain of Colicin E3
CdiA-CTECL shares no structural homology with previously char-
acterized CDI toxins from E. coli EC869 and B. pseudomallei
1026b (Morse et al., 2012; Nikolakakis et al., 2012). Searches
for structural homologs using the DALI server (Holm and
Rosenstro¨m, 2010) revealed that CdiA-CTECL is similar to the
C-terminal nuclease domain of colicin E3 (ColE3-CT). Colicin
E3 is a plasmid-encoded bacteriocin found in some E. coli
strains, and its nuclease domain cleaves 16S rRNA between
residues A1493 and G1494 (E. coli numbering) to interfere
with protein synthesis (Lancaster et al., 2008; Ng et al., 2010).
The CdiA-CTECL and ColE3-CT domains share a twisted anti-
parallel b sheet and superimpose with a root-mean-square devi-
ation (rmsd) of 2.1 A˚ over 76 a carbons, corresponding to a
Z score of 4.8, whereas the sequence identity between the two
domains is approximately 18% (Figures 2A and S2A). Residues
Asp510, His513, and Glu517 of colicin E3 are thought to functionreserved
Table 1. Crystallographic Statistics for the CdiA-CTECL/CdiIECL Protein Complex
Peak Remote Inflection Native
Space group P4122 P4122 P4122 P4122
Unit cell dimensions (A˚) 85.64 85.64 75.17 85.64 85.64 75.17 85.64 85.64 75.17 85.25 85.25 74.91
pH of crystallization condition 5.1 5.1 5.1 5.1
Protein concentration (mg/ml) 9 9 9 9
Data set
Wavelength (A˚) 0.9759 1.377 0.9794 1
Resolution range 50–2.85 50–3.0 50–2.9 50–2.4
Unique reflections (total) 5,486 (191,798) 4,645 (163,018) 5,179 (181,470) 11,315 (324,387)
Completeness (%)a 100.0 (100.0) 100.0 (100) 100.0 (100.0) 100 (100)
Redundancy a 27.8 (28.8) 27.6 (28.5) 27.8 (28.7) 28.7 (29.3)
Rmerge
a,b 0.114 (0.47) 0.129 (0.501) 0.109 (0.445) 0.088 (0.455)
I/sa 31.1 (10.42) 27.8 (8.7) 34.8 (10.8) 44.7 (11)
NCS copies 1 1
No. of selenium sites/a.u. 6
Figure of merit 0.49
Model refinement
Resolution range (A˚) 38.125–2.400
No. of reflections (working/free) 11,291/538
No. of protein atoms 1760
No. of water molecules 62
Missing residues CdiA-CT 1-159
Rwork/Rfree
c (%) 18.3/23.7
Rmsd
Bond lengths (A˚) 0.008
Bond angles (degrees) 1.15
Ramachandran plot
Most favorable region (%) 93.61
Additional allowed region (%) 6.39
Disallowed region 0.0
PDB ID code 4NTQ
aStatistics for the highest-resolution shell are given in brackets.
bRmerge = SjI  < I > j/SI.
cRwork = SjFobs-Fcalcj/SFobs Rfree was computed identically, except where all reflections belong to a test set of 10% randomly selected data.
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A CDI Toxin from Enterobacter cloacaedirectly in catalysis (Ng et al., 2010; Soelaiman et al., 2001;
Walker et al., 2004), and CdiA-CTECL residues Asp203,
Asp205, and Lys214 superimpose upon these colicin E3
active-site residues (Figures 2B and S2A). Together, these struc-
tural similarities suggest that CdiA-CTECL may share 16S rRNA
nuclease activity with colicin E3.
Although the CdiA-CTECL and ColE3-CT toxin domains
are structurally similar, the corresponding immunity proteins
are not related to one another in either primary or tertiary
structure (Figures S3A and S3B). The colicin E3 immunity protein
(ImE3) is significantly smaller than CdiIECL (9.9 versus
16.9 kDa), and the two proteins have different folds (Figure S3B).
A DALI search reveals that CdiIECL is most similar to the Whirly
family of single-stranded DNA binding proteins (Desveaux
et al., 2005). The closest structural homologs are two proteins
of unknown function from cyanobacteria (Protein Data Bank
[PDB] ID codes 2IT9 and 2NVN), which superimpose onto
CdiIECL with rmsds of 3.6–4.0 A˚ over 120–122 a carbons (Fig-Structure 22ure S3C). CdiIECL and ImE3 also bind their cognate toxins
differently. ImE3 binds to an ‘‘exosite’’ that leaves the colicin
E3 active site exposed (Carr et al., 2000), whereas CdiIECL binds
directly over the predicted active site (Figure 2C). Structural
alignment of the complexes shows that immunity protein binding
occurs at distinct non-overlapping positions (Figure 2D).
Interestingly, ColE3-CT contains a C-terminal extension not
found in CdiA-CTECL (Figure 2A). This C-terminal tail forms
a short a helix in one ColE3-CT structure (Soelaiman et al.,
2001), and this element would likely interfere with CdiIECL
binding were it present in CdiA-CTECL. Similarly, the orientation
of loop L2 differs considerably between the toxins (Figure 2A),
and these loops could block the binding of non-cognate
immunity proteins (Figure 2D). Despite these differences, each
immunity protein is predicted to prevent its cognate toxin from
entering the ribosome A site (Figures S4) (Ng et al., 2010), and
therefore toxin inactivation is fundamentally the same for both
systems., 707–718, May 6, 2014 ª2014 Elsevier Ltd All rights reserved 709
Figure 1. Structure of the CdiA-CT/CdiIECL Complex
(A) The CdiA-CTECL toxin (teal) and CdiIECL immunity protein (salmon pink) are depicted in ribbon representation with secondary structure elements. The amino
and carboxyl termini are indicated by (N) and (C), respectively. CdiIECL elements are denoted with a prime symbol (0) to differentiate them from the toxin secondary
structure elements.
(B) The CdiA-CT/CdiIECL interface is mediated by an extensive network of ion-pair and H-bond interactions. Interacting residues are shown as sticks with oxygen,
and nitrogen atoms are colored red and blue, respectively.Watermolecules are depicted as red spheres, and interacting bonds are depicted as black dotted lines.
(C) The CdiA-CT/CdiIECL interface also contains hydrophobic interactions mediated by the residues indicated in one-letter code. The view in (B) represents a 90
clockwise rotation of (A) and (C).
Also see Figure S1.
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A CDI Toxin from Enterobacter cloacaeCdiA-CTECL Cleaves 16S rRNA In Vivo to Inhibit Cell
Growth
The structural resemblance of CdiA-CTECL to ColE3-CT sug-
gests that the CDI toxin also cleaves 16S rRNA. To test this
prediction, we cloned cdiA-CTECL under the control of an arabi-
nose-inducible promoter and asked whether 16S rRNA is
cleaved upon induction with L-arabinose. E. coli cells carrying
the cdiA-CTECL construct do not growwhen themedia is supple-
mented with L-arabinose (Figure 3A), confirming that CdiA-
CTECL is an inhibitory toxin. We isolated total RNA from the
inhibited cells and analyzed 16S rRNA by northern blot. This
analysis revealed that 16S rRNA is cleaved in cells expressing
cdiA-CTECL but remains intact in control cells that carry the
vector plasmid alone (Figure 3B).We next testedCdiIECL function
to determine whether it neutralizes the growth inhibition and
nuclease activities of CdiA-CTECL. We cloned cdiIECL under the
control of an isopropyl b-D-1-thiogalactopyranoside-inducible
promoter and introduced the resulting plasmid into cells that
harbor the arabinose-inducible cdiA-CTECL construct. Cells
expressing both cdiA-CTECL and cdiIECL grow at the same rate
as control cells that carry empty vector plasmids (Figure 3A),
indicating that CdiIECL prevents CdiA-CTECL-mediated growth
inhibition. Furthermore, northern analysis shows that 16S rRNA
is not cleaved in cells that coexpress cdiA-CTECL and cdiIECL
(Figure 3B), demonstrating that the immunity protein also blocks
nuclease activity. Together, these results show that CdiA-CTECL
and CdiIECL constitute a cognate toxin/immunity pair that targets
the ribosome.
CdiIECL Immunity Function Is Specific for Its Cognate
Toxin
At least one other CdiA protein is predicted to possess 16S
rRNase activity. Walker et al. (2004) discovered that HecA from
Erwinia chrysanthemi EC16 contains the same catalytic motif
as colicin E3 (Figure S2B). HecA was originally identified as an
adhesin that promotes bacterial colonization of plant hosts710 Structure 22, 707–718, May 6, 2014 ª2014 Elsevier Ltd All rights(Rojas et al., 2002, 2004), but this protein shares 68% sequence
identity with a known CdiA effector (Uniprot ID code E0SCQ6)
from Dickeya dadantii 3937 (Aoki et al., 2010). Together, these
observations suggest that HecA actually functions in CDI, and
therefore we refer to this protein as CdiAEC16. To test toxin
activity, we cloned the cdiA-CTEC16 sequence under control of
an arabinose-inducible promoter for expression in E. coli cells.
As predicted, cell growth is inhibited when cdiA-CTEC16 expres-
sion is induced (Figure 3C), and northern analysis shows 16S
rRNA cleavage in the inhibited cells (Figure 3D). Because CDI
systems are always arranged as toxin/immunity gene pairs, we
tested the small open reading frame found immediately down-
stream of cdiAEC16 for immunity function. The predicted cdiIEC16
gene blocks the growth inhibition and nuclease activities asso-
ciated with cdiA-CTEC16 expression (Figures 3C and 3D). CdiA-
CTEC16 and CdiIEC16 do not share significant sequence identity
with the toxin/immunity proteins from E. cloacae (Figure S2;
data not shown), suggesting that each immunity protein is
specific for its cognate toxin. Indeed, we found that cdiIECL
and cdiIEC16 only protect cells from the inhibitory effects of their
corresponding toxins (Figures 3A and 3C). Similarly, each immu-
nity gene specifically blocks the nuclease activity associated
with its cognate toxin (Figures 3B and 3D). Thus, although
CdiA-CTECL and CdiA-CTEC16 share a common growth inhibition
activity, the associated immunity proteins only provide protec-
tion against their cognate toxins.
Purified CdiA-CTECL and CdiA-CTEC16 Cleave 16S rRNA
In Vitro
In principle, CdiA-CTECL and CdiA-CTEC16 could induce an
endogenous nuclease activity that actually catalyzes 16S
rRNA cleavage. Therefore, we tested purified toxins for nuclease
activity in vitro. Each CdiA-CT/CdiI-His6 pair was first purified as
a complex. Toxinswere then eluted away from immunity proteins
using Ni2+-affinity chromatography under denaturing conditions.
Purified toxins were refolded by dialysis against non-denaturingreserved
Figure 2. CdiA-CTECL Share Structural Similarities with the Nuclease Domain of Colicin E3
(A) Superimposition of CdiA-CTECL (teal) and the C-terminal nuclease domain of colicin E3 (ColE3-CT, orange) (PDB ID code 2B5U). The toxin domains
superimpose with an rmsd of 2.1 A˚.
(B) Colicin E3 residues Asp510, His513, and E517 are involved in catalysis and superimpose with residues Asp203, Asp205, and Lys214 of CdiA-CTECL. His207 of
CdiA-CTECL is located within disordered loop L4 and is modeled as an alanine residue. Residues are indicated in one-letter code and rendered as stick
representations.
(C) The predicted CdiA-CTECL active site is occluded by bound CdiIECL. Interacting bonds are represented by black dotted lines.
(D) Superimposition of CdiA-CT/CdiIECL with the ColE3-CT/ImE3 complex. Ribbon representations of CdiA-CTECL (teal), CdiIECL (salmon pink), ColE3-CT
(orange), and ImE3 (yellow) are depicted.
Also see Figures S2 and S3.
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A CDI Toxin from Enterobacter cloacaebuffer prior to activity assays. Before testing nuclease activity,
we first confirmed that each refolded CdiA-CT is able to rebind
its cognate immunity protein. We mixed CdiI-His6 with either
cognate or non-cognate toxin and subjected the mixtures to
Ni2+-affinity chromatography under non-denaturing conditions.
Each CdiA-CT copurified with its cognate immunity protein (Fig-
ure 4A), indicating that the toxins can re-establish specific
binding interactions after denaturation and refolding. We next
treated ribosomes with purified toxins and analyzed the reac-
tions by northern blot hybridization. Both CdiA-CTECL and
CdiA-CTEC16 cleave a 30-fragment from 16S rRNA, and the ac-
tivity of each toxin is effectively blocked by equimolar cognate
CdiI protein (Figure 4B). These results indicate that each toxin
is directly responsible for 16S rRNA cleavage.
Next, we used primer extension to determine whether the CDI
toxins cleave 16S rRNA at the same position as colicin E3.
We generated an oligonucleotide that hybridizes to residuesStructure 22C1501–C1521 of E. coli 16S rRNA (Figure 5A) and used it as a
primer in reverse transcription reactions to screen for cleavage
sites. Residue U1498 of 16S rRNA is methylated at the N3
position (Figure 5A), and this modified base is predicted to inter-
fere with reverse transcription. Therefore, we repeated the
in vitro nuclease reactions using ribosomes isolated from an
E. coli DrsmE::kan mutant, which lacks the U1498 methyltrans-
ferase (Basturea et al., 2006). Analysis of these nuclease reac-
tions shows a strong primer-extension arrest corresponding to
residue G1494 (Figures 5A and 5B). This primer extension prod-
uct is neither observed when ribosomes are mock-treated with
buffer nor when the reactions contain equimolar cognate CdiI
protein (Figure 5B). These data are consistent with CdiA-CT-
mediated cleavage of the phosphodiester bond linking residues
A1493 and G1494 (Figure 5A). Thus, CdiA-CTECL and CdiA-
CTEC16 both appear to cleave 16S rRNA at the same site as
colicin E3., 707–718, May 6, 2014 ª2014 Elsevier Ltd All rights reserved 711
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Figure 3. CdiA-CT Toxin Activity In Vivo
(A) cdiA-CTECL expression was induced at 0 hr, and cell growth was monitored by measuring the culture optical density at 600 nm (OD600). Red curves are from
cells that lack an immunity gene; the green and blue curves represent cells that express cdiIECL and cdiIEC16, respectively. The black curve shows cell growth in
the absence of toxin expression.
(B) Total RNA was isolated from the cells in (A) and analyzed by northern blot using a probe to the 30-end of E. coli 16S rRNA. Toxin and immunity genes are
indicated as ECL for E. cloacae and EC16 for E. chrysanthemi EC16. The migration positions of full-length and cleaved 16S rRNA are indicated.
(C) cdiA-CTEC16 expression was induced and cell growth monitored as outlined in (A).
(D) RNA was isolated from the cells in (C) and analyzed as described for (B).
Also see Figure S4.
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Identified in the CdiA-CTECL Structure
The side chains of CdiA-CTECL Asp203 and Lys214 overlay
with active-site residues Asp510 and Glu517 (respectively) of
colicin E3 (Figures 2B and S2A). However, because loop L4
is not well resolved in the CdiA-CTECL structure, it is difficult
to unambiguously identify a catalytic residue corresponding
to His513 of colicin E3. Therefore, we mutated CdiA-CTECL
residues Asp203, Asp205, His207, and Lys214 individually to
alanine and tested the resulting proteins for toxicity in vivo
and 16S rRNase activity in vitro. CdiA-CTECL variants containing
Asp203Ala, His207Ala, or Lys214Ala mutations have no effect
on E. coli cell growth (Figure 6A), suggesting that nuclease
activity is disrupted. The Asp205Ala variant shows a delayed in-
hibition phenotype, in which cell growth is arrested 90 min
after toxin expression is induced (Figure 6A). Comparable re-
sults were obtained with in vitro reactions using purified toxin
variants. CdiA-CTECL carrying the Asp203Ala, His207Ala, and
Lys214Ala mutations has no detectable rRNase activities
in vitro, whereas the Asp205Ala variant exhibits lower activity
than the wild-type enzyme (Figure 6B). We note that all CdiA-
CTECL variants appear to be folded properly, because each pro-
tein efficiently rebinds cognate CdiIECL immunity protein in vitro712 Structure 22, 707–718, May 6, 2014 ª2014 Elsevier Ltd All rights(Figure 6C). Together, these experiments indicate that Asp203,
His207, and Lys214 are required for toxin activity and could
function in catalysis, whereas Asp205 plays an important, yet
non-essential, role.
CdiA-CTECL Is Delivered into Target Bacteria during CDI
Next, we asked whether the E. cloacae CDI system is expressed
and deployed for competition. We reasoned that E. cloacae
mutants lacking the immunity gene should be susceptible to
inhibition. We deleted the cdiAECL and cdiIECL genes and tested
the resulting double mutant strain in competition cocultures with
wild-type E. cloacae cells.We found that the E. cloacaeDcdiAECL
DcdiIECL mutants are not inhibited by wild-type cells in either
liquid or solid media (Figure 7A, gray bars; data not shown),
suggesting that the CDIECL system is not functional or may not
be expressed under laboratory conditions. Therefore, we intro-
duced the E. coli araBAD promoter upstream of the E. cloacae
cdi locus to allow inducible expression and used this inhibitor
strain for competitions on solid growth media. When the CDIECL
system is induced, the growth of target cells is suppressed
approximately 20-fold compared to cocultures with E. cloacae
cells carrying the wild-type cdi locus (Figure 7A, compare white
to gray bars). Moreover, target cell growth is restored if theyreserved
AB
Figure 4. CdiA-CT Toxin Activity In Vitro
(A) Purified CdiA-CT toxins and CdiI-His6 immunity proteins were mixed and
then subjected to Ni2+-affinity chromatography under non-denaturing condi-
tions. Lanes labeled input represent CdiA-CT/CdiI-His6 mixtures prior to
chromatography; lanes labeled free are proteins that fail to bind Ni2+-resin; and
lanes labeled bound are proteins that elute with imidazole.
(B) Isolated E. coli ribosomes were treated with purified CdiA-CTECL and CdiA-
CTEC16, and the reactions analyzed by northern blot using a probe to the 30-end
of 16S rRNA. Where indicated, CdiI-His6
ECL (ECL) or CdiI-His6
EC16 (EC16) was
added at an equimolar ratio to the toxin. Mock reactions are ribosome samples
that were treated with buffer. Themigration positions of full-length and cleaved
16S rRNA are indicated.
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A CDI Toxin from Enterobacter cloacaecarry a plasmid-borne copy of the cdiIECL immunity gene, but the
non-cognate cdiIEC16 gene provides no protection (Figure 7A).
We also tested the inducible E. cloacae inhibitor cells in cocul-
tures with E. coli target cells. Because E. cloacae ATCC 13047
uses one of its type VI secretion systems to inhibit E. coli
(Ruhe et al., 2013b), we first deleted the tssM1 gene
(ECL_01536) from the E. cloacae inhibitor strain to inactivate
type VI secretion. Remarkably, E. coli cells are more sensitiveStructure 22to growth inhibition, with viable target cell counts reduced
100-fold after 4 hr of coculture (Figure 7B). Notably, E. coli
cell growth is unaffected during coculture with E. cloacae
containing the wild-type cdi locus (Figure 7B), again indicating
that the CDIECL system is not expressed on labmedia. Moreover,
E. coli targets are protected by plasmid-borne cdiIECL, but not by
cdiIEC16 (Figure 7B), confirming that growth inhibition is due to
CdiA-CTECL toxin activity.
Many CdiA-CT toxins are modular and can be exchanged
between different CdiA proteins to generate functional effector
molecules (Aoki et al., 2010; Morse et al., 2012; Nikolakakis
et al., 2012; Webb et al., 2013). To test whether the CdiA-CT/
CdiIECL toxin/immunity protein complex is functional in the
context of another CDI system, we replaced the cdiA-CT/
cdiIEC93 region of the E. coli EC93 CDI system with the
E. cloacae toxin/immunity coding sequences. This fusion pro-
duces a chimeric CdiA protein with CdiA-CTECL grafted onto
CdiAEC93 at the VENN peptide motif. E. coli cells expressing
the cdiAEC93-CTECL chimera are potent inhibitors, capable of
reducing viable E. coli target cells 104-fold after 3 hr of cocul-
ture (Figure 8A). Again, target cells that carry the cdiIECL immu-
nity gene are not inhibited and grow to the same level as cells
cultured with mock-inhibitor cells that lack a CDI system (Fig-
ure 8A). However, target cells expressing non-cognate cdiIEC16
are inhibited to the same extent as cells that carry no immunity
gene (Figure 8A). Because the inhibition effect is so profound
in these co-culture experiments, we asked whether toxin-
damaged ribosomes could be detected in the target cells. We
isolated total RNA from each competition coculture and per-
formed northern blot analysis to assay for RNase activity.
Cleaved 16S rRNA is readily detected when the target cells
lack immunity or express non-cognate cdiIEC16 immunity, but
this nuclease activity is not observed when target cells carry
the cognate cdiIECL gene (Figure 8B). We also generated and
tested inhibitor cells that express chimeric cdiAEC93-CTECL
containing the His207Ala active-site mutation. Cells expressing
the mutant effector do not inhibit E. coli targets, and no 16S
rRNA cleavage is detected in the competition coculture (Figures
8A and 8B). Together, these results demonstrate that the
CdiA-CTECL toxin is delivered into target bacteria during CDI
and that 16S RNase activity is solely responsible for growth
inhibition.
DISCUSSION
CdiA proteins carry a variety of sequence-diverse C-terminal
domains, which represent a collection of distinct toxins. Deter-
mining the biochemical activities of so many different toxins
remains an important problem in the field (Aoki et al., 2010;
Ruhe et al., 2013a). Zhang et al. (2012) have successfully used
comparative sequence analyses to predict that many CdiA-CT
toxins have nuclease activities. However, these predictions often
do not identify specific nucleic acid substrates and may be inac-
curate in some instances. In fact, the current annotation for
CdiA-CTECL (Pfam PF15526; http://pfam.sanger.ac.uk/family/
Toxin_46) suggests that this toxin adopts a Barnase-EndoU-
colicin E5/RelE (BECR) protein fold and targets tRNA molecules
for cleavage. The work presented here demonstrates that
CdiA-CTECL is actually most similar to the C-terminal nuclease, 707–718, May 6, 2014 ª2014 Elsevier Ltd All rights reserved 713
A B Figure 5. CdiA-CTECL and CdiA-CTEC16
Cleave 16S rRNA between A1393 and G1394
(A) Nucleotide sequence and secondary structure of
the 30S subunit decoding center. The sequence of
the reverse transcription (RT) primer is shown in
heteroduplex with its complementary sequence in
16S rRNA. Oligonucleotides C1496, G1494, and
G1491 were used as gel migration standards. The
16S rRNA cleavage site is indicated by an arrow.
(B) Ribosomal RNA was extracted from the indi-
cated in vitro nuclease reactions and hybridized
to radiolabeled RT primer for primer extension
analysis using reverse transcriptase. Reactions
were resolved on a denaturing gel and visualized
by phosphorimaging. The migration positions of
oligonucleotides C1496, G1494, and G1491 are
indicated.
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A CDI Toxin from Enterobacter cloacaedomain of colicin E3. Consistent with this structural homology,
CdiA-CTECL is a site-specific 16S rRNase rather than a tRNase.
Furthermore, we note that even accurate protein-fold predic-
tions can lead to erroneous assignments of biochemical activity.
For example, CdiA-CTBp1026b from B. pseudomallei 1026b has
the same fold as type IIS restriction endonucleases, yet this toxin
is a specific tRNase and has no detectable DNase activity (Morse
et al., 2012; Nikolakakis et al., 2012). These discrepancies be-
tween prediction and experimental characterization underscore
the need for careful biochemical analysis to test sequence-
based hypotheses.
The activity of colicin E3 was first described over 40 years ago
(Bowman et al., 1971; Senior and Holland, 1971), yet a catalytic
mechanism has only recently been proposed based on the struc-
ture of the enzyme bound to the ribosome (Ng et al., 2010). The
mechanistic model postulates that Glu517 of colicin E3 acts as a
general base to abstract a proton from the 20-OH of 16S rRNA
residue A1493. The resulting alkoxide subsequently attacks the
phosphodiester linking A1493 and G1494 to cleave the 16S
rRNA chain. The side chain of His513 is thought to stabilize the
transition state as well as donate a proton to the 50-OH leaving
group after cleavage. Colicin E3 residues Asp510 and Glu515
are within H-bonding distance of His513 and may promote
protonation of its imidazole ring (Ng et al., 2010). Comparative
structure analysis suggests that residues Asp203, Asp205, and
Lys214 of CdiA-CTECL are involved in catalysis because they
are in the same relative positions as Asp510, His513, and
Glu517 (respectively) of colicin E3. The superimposition of these
residues is remarkable given that loop L4 of CdiA-CTECL, which
contains the predicted active-site residues, is significantly longer
and more flexible than the corresponding region in colicin E3
(see Figure 2A). Mutagenesis experiments confirm that these
CdiA-CTECL residues are important for nuclease activity, but it
is not clear that the two enzymes share the same catalytic mech-
anism. For example, Lys214 in CdiA-CTECL is unlikely to function
as a generalized base as proposed for Glu517 of ColE3-CT,
especially as nearby residues Asp203 and Asp205 within714 Structure 22, 707–718, May 6, 2014 ª2014 Elsevier Ltd All rights reservedCdiA-CTECL should favor protonation of
Lys214. Lysine residues are often found
in the active sites of nucleases and typi-
cally function to position the scissile phos-phodiester or stabilize pentavalent transition states (Gite et al.,
1992; Pingoud and Jeltsch, 2001; Richardson et al., 1990).
Therefore, it seems likely that Lys214 serves one of the afore-
mentioned functions, leaving His207 to act as the general base
that initiates 16S rRNA cleavage. Though we have no structural
information for CdiA-CTECL bound to the ribosome, the available
data suggest that colicin E3 and CdiA-CTECL probably utilize
distinct catalytic strategies.
The lack of sequence identity between CdiA-CTECL and
ColE3-CT also raises questions about how the CDI toxin binds
to the ribosome. Ng et al. (2010) have shown that ColE3-CT loop
L2 makes a number of specific contacts with the ribosome A
site. Residues Arg495 and Gln489 bind the nucleobase and
phosphate of 16S rRNA residue A1493; Lys496 interacts with
C518; and Lys494 holds G530 in the syn conformation through
a bridging water molecule (Ng et al., 2010). These toxin residues
are highly conserved between colicins E3, E4, and E6 and clo-
acin DF, suggesting that these enzymes all bind the ribosome in
the same manner. By contrast, not one of these loop L2 resi-
dues is shared with CdiA-CTECL (see Figure S2A). In fact, loop
L2 of CdiA-CTECL is significantly displaced compared to
ColE3-CT. This displacement may result from the binding of
CdiIECL, which would clash with loop L2 if it were in the
ColE3-CT conformation. In the absence of CdiIECL, it is possible
that loop L2 of CdiA-CTECL adopts the same conformation seen
in ColE3-CT, but the sequence divergence suggests that each
loop makes distinct contacts with the ribosome. ColE3-CT
makes additional contacts with ribosomal protein S12 within
the A site. Residues Tyr460–Tyr464 form an intriguing pseudo-
b sheet interaction with the side chains from His462, Asp463,
and Tyr464, making specific H-bond contacts with S12 (Ng
et al., 2010). Unfortunately, the corresponding region of CdiA-
CTECL was degraded during crystallization, precluding a direct
comparison of these structures. But again, the primary
sequences in this region share no obvious homology, indicating
that the two toxins probably interact with ribosomal protein S12
in distinct manners.
AC
B Figure 6. Mutagenesis of Predicted Active-
Site Residues in CdiA-CTECL
(A) Expression of cdiA-CTECL and the indicated
mutated variants were induced at 0 hr with L-arab-
inose and cell growth monitored by measuring the
optical density of the culture at 600 nm (OD600). The
black curve shows the growth of a control culture
without toxin expression.
(B) Isolated E. coli ribosomes were treated with
purified CdiA-CTECL toxins and RNA extracted for
northern blot analysis. Where indicated, purified
CdiI-His6
ECL was included in the reaction. The gel
migration positions of full-length and cleaved 16S
rRNA are indicated.
(C) Purified CdiA-CT toxins and CdiI-His6 immunity
proteins were mixed and then subjected to Ni2+-
affinity chromatography under non-denaturing
conditions. Lanes labeled input represent CdiA-CT/
CdiI-His6 mixtures prior to chromatography; lanes
labeled free are proteins that fail to bind Ni2+-resin;
and lanes labeled bound are proteins that elute with
imidazole.
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A CDI Toxin from Enterobacter cloacaeFinally, we note that there are several fundamental
differences between CdiIECL and ImE3 immunity proteins.
CdiIECL and ImE3 differ significantly in molecular mass, share
less than 12% sequence identity, and bind to non-overlapping
sites on their cognate nuclease domains. Moreover, each
immunity protein has a distinct tertiary structure and fold.
Structural homology searches reveal that CdiIECL is most
similar to the Whirly family of single-stranded DNA-binding
proteins. Although this homology is relatively weak (Z scores
4.1 to 4.3 and rmsd 4.0 A˚), CdiIECL shares a characteristic
topology with all Whirly proteins (see Figure S3B). The fact
that the immunity proteins for colicin E3 and CdiA-CTECL toxins
are unrelated in both primary sequence and tertiary structure
suggests that these toxin-immunity pairs have independent
origins. Because cognate toxin/immunity gene pairs are
closely linked, they must presumably coevolve as a unit. This
process is thought to involve initial changes in the immunity
protein, followed by compensatory mutations in the toxin
that restore high-binding affinity between the two proteins
(Riley, 1993; Tan and Riley, 1997). In general, there are few
constraints to impede the drift of immunity genes, becauseStructure 22, 707–718, May 6, 201they need only encode proteins that
bind toxins. By contrast, toxins are
often enzymes and must retain the
ability to bind substrates and catalyze
reactions. This model is largely sup-
ported by analyses showing that im-
munity proteins diverge more rapidly
than do toxins (Ruhe et al., 2013a; Tan
and Riley, 1997). Thus, although it is
formally possible that ImE3 and CdiIECL
arose from a common ancestor, the
differences in immunity protein folds
make this model much less likely. Based
on this reasoning, we speculate that
CdiA-CTECL/CdiIECL and ColE3-CT/ImE3
evolved from different lineages and thatthe structural and enzymatic similarities between the toxins
reflect convergent evolution.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Growth Conditions
All bacterial strains and plasmids used in this study are listed in Table S2.
Bacteria were grown in lysogeny broth media or LB-agar with the appropriate
antibiotics as described in the Supplemental Experimental Procedures.
E. cloacae genes were deleted using the same protocol as that described
for E. coli (Hayes et al., 2002). DNA sequences located upstream and down-
stream of target genes were amplified and cloned into plasmid pKAN or
pSPM (Koskiniemi et al., 2013) to flank kanamycin or spectinomycin resistance
cassettes, respectively. The resulting plasmids were linearized by restriction
endonuclease digestion and electroporated into E. cloacae cells expressing
the phage l Red proteins from plasmid pKOBEG (Pe´rez et al., 2007). The
details of all strain and plasmid constructions are provided in the Supplemental
Experimental Procedures.
Protein Purification and Crystallography
CdiA-CT/CdiI-His6 complexes were purified and the toxin and immunity
proteins isolated from one another as described previously (Diner et al.,
2012; Nikolakakis et al., 2012). The CdiA-CT/CdiIECL complex was crystallized4 ª2014 Elsevier Ltd All rights reserved 715
AB
Figure 8. The CdiA-CTECL Toxin Domain Is Modular
(A) E. coli target cells were cocultured with inhibitor cells that express chimeric
CdiAEC93-CTECL in broth. Where indicated, target cells were provided with
plasmid-borne copies of the cdiIECL or cdiIEC16 immunity genes. The inhibitors
labeled H207A express CdiAEC93-CTECL containing the His207Ala mutation in
the toxin domain. Mock inhibitors lack the CDI system. Viable target cell
counts were determined as CFU/ml, and data are reported as themean ± SEM
for two independent experiments.
(B) Total RNA was isolated from the co-culture experiments described in (A)
and analyzed by northern blot using a probe to the 30-end of 16S rRNA.
A
B
Figure 7. Intercellular Competitions with E. cloacae Inhibitor Cells
(A) Intra-species competition. E. cloacae inhibitor cells were cocultured with
E. cloacae DcdiAECL DcdiIECL target cells on LB-agar supplemented with
arabinose. Where indicated, target cells were provided with plasmid-borne
cdiIECL or cdiIEC16 immunity genes. Total viable target cells were determined as
colony-forming units. White bars correspond to competitions with arabinose-
inducible inhibitor cells (PBAD-cdiBAI
+), and gray bars correspond to compe-
titions with inhibitors that carry the wild-type locus (cdiBAI+).
(B) Inter-species competition. E. cloacae inhibitor cells were cocultured with
E. coli target cells on LB-agar supplemented with arabinose. Where indicated,
the target cells were provided with plasmid-borne cdiIECL or cdiIEC16 immunity
genes. Viable target cells were determined as colony-forming units (CFU), and
data are reported as the mean ± SEM for two independent experiments.
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A CDI Toxin from Enterobacter cloacaeas described previously (Goulding and Perry, 2003). Crystals were grown at
room temperature by hanging drop-vapor diffusion with a reservoir containing
1.5 M (NH4)2SO4, 0.1 M Bis Tris (pH 5.1), and 1% (wt/vol) PEG 3350. The
structural model was determined as described previously (Morse et al.,
2012). Non-optimal detector positioning during data collection necessitated
the high-resolution limit of 2.4 A˚. All crystallography and refinement statistics
are presented in Table 1. Atomic coordinates and structure factors have
been deposited in the PDB (http://www.pdb.org) with the ID code 4NTQ.
Nuclease Assays
Ribosomes were isolated from S30 lysates of E. coli as described (Diner and
Hayes, 2009) and incubated with purified CdiA-CT toxins and CdiI immunity
proteins as described in the Supplemental Experimental Procedures. All reac-
tions were analyzed by northern blot using a probe complementary to the
30-end of E. coli 16S rRNA. CdiA-CT cleavage sites were determined using
ribosomes from E. coli DrsmE cells. Reactions were quenched with guanidi-
nium isothiocyanate-phenol and rRNA extracted for primer extension analysis
as described previously (Diner and Hayes, 2009).716 Structure 22, 707–718, May 6, 2014 ª2014 Elsevier Ltd All rightsGrowth Competitions
E. cloacae inhibitor cells were cocultured with E. cloacaeDcdiAI target cells on
LB-agar supplemented with 0.2% L-arabinose. Cells were harvested and
enumerated as colony-forming units (CFU). Immunity function was evaluated
through expression of cdiI genes in target cells from plasmid constructs as
described in the supplement. Cross-species competitions were performed
under the same conditions using E. coli target cells. Chimeric EC93-ECL
CDI systems were expressed from cosmids in E. coli EPI100. Inhibitor cells
were coculturedwith target cells in LBmedia. Samples were taken for enumer-
ation of viable target cells. E. coli EPI100 cells carrying cosmid pWEB-TNC
were used as mock (CDI) inhibitors.
ACCESSION NUMBERS
Atomic coordinates and structure factors have been deposited in the Protein
Data Bank (http://www.pdb.org) with the ID code 4NTQ.
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